PALI- Palisade Bio, Inc.
Palisade Bio, Inc. (PALI) has 7 insiders with recent SEC Form 4 filings, including 10 buys and 2 sells. PALI is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.51M | $3.20M | - | |
| Dir | 613.4K | $1.30M | - | |
| Dir | 592.3K | $1.26M | - | |
| Dir | 416.9K | $883.8K | - | |
| Dir | 336.9K | $714.2K | - |
Activity
Buys and sells only
Transactions
10 filings
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 7, 2026 | Finley John David | CEO, CFO | Sale+OE | 146,798 | $2.07 | $303,343.39 | -40.3% | - | - | |
| Jul 7, 2026 | Jones Mitchell Lawrence | Chief Medical Officer | Sale+OE | 51,880 | $2.05 | $106,535.58 | -35.6% | - | - | |
| Jul 7, 2026 | Baltera Robert Jr. | Director | Buy | 50,000 | $2.04 | $102,084.00 | +6.6% | - | - | |
| Jul 2, 2026 | Baltera Robert Jr. | Director | Buy | 30,000 | $1.98 | $59,400.00 | +4.3% | - | - | |
| Jan 16, 2026 | Williams Donald Allen | Director | Buy | 5,000 | $1.67 | $8,356.00 | +87.3% | - | - | |
| Jan 9, 2026 | Williams Donald Allen | - | Buy | 5,000 | $1.88 | $9,400.00 | +686.8% | -0.5% | - | |
| May 28, 2024 | Williams Donald Allen | Director | Buy | 1,000 | $4.86 | $4,863.00 | New | -27.7% | -83.9% | |
| May 24, 2024 | Finley John David | CEO, CFO, Director | Buy | 1,000 | $4.81 | $4,810.00 | +13.4% | -26.9% | -83.6% | |
| Feb 6, 2024 | Finley John David | CEO, CFO, Director | Buy | 10,000 | $0.47 | $4,692.00 | +13.4% | +24.3% | -80.5% | |
| Jan 31, 2024 | Finley John David | CEO, CFO, Director | Buy | 10,000 | $0.56 | $5,590.00 | +15.5% | -32.9% | -84.1% |
Page 1Next →